LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,392,429 | -16.7% | 71,352 | -1.1% | 0.01% | -14.3% |
| Q2 2023 | $5,271,854 | +1.8% | 72,148 | +0.7% | 0.01% | -12.5% |
| Q1 2023 | $5,178,714 | +6.2% | 71,643 | -3.0% | 0.01% | 0.0% |
| Q4 2022 | $4,877,095 | -20.1% | 73,873 | +5.6% | 0.01% | -20.0% |
| Q3 2022 | $6,102,000 | +0.2% | 69,940 | -0.3% | 0.01% | +11.1% |
| Q2 2022 | $6,089,000 | -28.1% | 70,175 | -3.0% | 0.01% | -18.2% |
| Q1 2022 | $8,464,000 | -24.2% | 72,343 | +1.3% | 0.01% | -15.4% |
| Q4 2021 | $11,169,000 | +10.3% | 71,436 | -0.7% | 0.01% | 0.0% |
| Q3 2021 | $10,125,000 | +5.6% | 71,967 | -1.5% | 0.01% | 0.0% |
| Q2 2021 | $9,585,000 | -3.8% | 73,064 | +12.6% | 0.01% | -7.1% |
| Q1 2021 | $9,962,000 | +51.4% | 64,908 | -1.9% | 0.01% | +27.3% |
| Q4 2020 | $6,582,000 | +61.6% | 66,179 | +59.3% | 0.01% | +37.5% |
| Q3 2020 | $4,073,000 | -56.8% | 41,536 | -49.7% | 0.01% | -20.0% |
| Q2 2020 | $9,418,000 | +210.8% | 82,530 | +100.9% | 0.01% | +42.9% |
| Q1 2020 | $3,030,000 | -26.8% | 41,081 | +4.2% | 0.01% | -12.5% |
| Q4 2019 | $4,139,000 | +7.9% | 39,419 | +2.7% | 0.01% | 0.0% |
| Q3 2019 | $3,837,000 | +30.6% | 38,382 | +49.1% | 0.01% | +14.3% |
| Q2 2019 | $2,938,000 | +31.7% | 25,737 | +45.0% | 0.01% | +40.0% |
| Q1 2019 | $2,231,000 | -70.4% | 17,747 | -68.1% | 0.01% | -16.7% |
| Q4 2018 | $7,548,000 | -26.1% | 55,611 | +49.5% | 0.01% | -45.5% |
| Q3 2018 | $10,210,000 | +208.7% | 37,202 | +133.1% | 0.01% | +37.5% |
| Q2 2018 | $3,307,000 | +0.3% | 15,963 | -20.1% | 0.01% | 0.0% |
| Q1 2018 | $3,298,000 | +32.0% | 19,970 | +9.4% | 0.01% | +33.3% |
| Q4 2017 | $2,499,000 | +6.4% | 18,251 | +5.8% | 0.01% | 0.0% |
| Q3 2017 | $2,348,000 | +15.4% | 17,249 | +2.9% | 0.01% | +20.0% |
| Q2 2017 | $2,035,000 | +31.1% | 16,760 | +14.3% | 0.01% | +25.0% |
| Q1 2017 | $1,552,000 | +34.8% | 14,663 | +29.4% | 0.00% | +33.3% |
| Q4 2016 | $1,151,000 | +6.9% | 11,328 | +7.4% | 0.00% | 0.0% |
| Q3 2016 | $1,077,000 | -12.2% | 10,552 | +2.6% | 0.00% | +50.0% |
| Q2 2016 | $1,226,000 | – | 10,284 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |